In an animal model of Parkinson’s disease (PD), in which dopamine neurons are depleted by 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP), UCP2 knockout increased whereas UCP2 overexpression decreased MPTP-induced nigral dopamine cell loss. Here, UCP2 is linked to Parkinson disease.